← FDA DRUG APPROVALS
FDA ANDA · ANDA209666
MILRINONE LACTATE
milrinone lactate in 5% dextrose
Sponsor: EUGIA PHARMA
APPLICATION
ANDA209666
TYPE
ANDA
ORIGINAL APPROVAL
2020-09-03
LATEST ACTION
2020-09-03
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
MILRINONE LACTATE IN DEXTROSE 5%Prescription
MILRINONE LACTATE EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) · INJECTABLE · INJECTION
MILRINONE LACTATE IN DEXTROSE 5%Prescription
MILRINONE LACTATE EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) · INJECTABLE · INJECTION
Approval history
2020-09-03UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.